CUC Résultats passés
Passé contrôle des critères 5/6
CUC has been growing earnings at an average annual rate of 18.4%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 23.3% per year. CUC's return on equity is 12.5%, and it has net margins of 9.1%.
Informations clés
18.4%
Taux de croissance des bénéfices
7.6%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 7.9% |
| Taux de croissance des recettes | 23.3% |
| Rendement des fonds propres | 12.5% |
| Marge nette | 9.1% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
CUC Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Oct 31
Does CUC (TSE:9158) Have A Healthy Balance Sheet?
Oct 29CUC (TSE:9158) May Have Issues Allocating Its Capital
Sep 04CUC Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 26Is CUC (TSE:9158) Using Too Much Debt?
Jul 17Take Care Before Jumping Onto CUC Inc. (TSE:9158) Even Though It's 27% Cheaper
Jun 15Results: CUC Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 28More Unpleasant Surprises Could Be In Store For CUC Inc.'s (TSE:9158) Shares After Tumbling 35%
Apr 27Ventilation des recettes et des dépenses
Comment CUC gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 39,290 | 3,565 | 14,343 | 0 |
| 30 Jun 24 | 35,959 | 3,079 | 13,129 | 0 |
| 31 Mar 24 | 33,025 | 2,595 | 9,833 | 0 |
| 31 Dec 23 | 31,133 | 1,779 | 11,432 | 0 |
| 30 Sep 23 | 31,862 | 1,952 | 10,802 | 0 |
| 30 Jun 23 | 32,737 | 1,992 | 10,459 | 0 |
| 31 Mar 23 | 35,210 | 2,423 | 10,015 | 0 |
| 31 Mar 22 | 35,314 | 2,707 | 8,788 | 0 |
| 31 Mar 21 | 16,606 | 1,100 | 5,711 | 0 |
Des revenus de qualité: 9158 has high quality earnings.
Augmentation de la marge bénéficiaire: 9158's current net profit margins (9.1%) are higher than last year (6.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 9158's earnings have grown by 18.4% per year over the past 5 years.
Accélération de la croissance: 9158's earnings growth over the past year (82.6%) exceeds its 5-year average (18.4% per year).
Bénéfices par rapport au secteur d'activité: 9158 earnings growth over the past year (82.6%) exceeded the Healthcare industry 9.6%.
Rendement des fonds propres
ROE élevé: 9158's Return on Equity (12.5%) is considered low.